Peter Teismann completed his Doctorate in pharmacology and toxicology at the University of Marburg in 2000. He then joined Professor Przedborski at the Columbia University, Manhattan, NY, USA, where he studied the role of cyclooxygenase-2 in a model of Parkinson?s disease as well as in patients. From there he moved to the University of Tubingen, Tubingen, Germany, and then the University of G?ttingen, G?ttingen, Germany, where he continued his work under the guidance of Professor J. Schulz. In 2005 he moved to the University of Aberdeen, Aberdeen, UK, where he established his own research group. Since then he has continued his work studying neuroinflammatory processes in Parkinson?s disease. Besides, he has established collaborations to study new imaging techniques to visualize Lewy bodies in Parkinson?s patients. Teismann also holds a patent for a neuroprotective compound, which he is further studying as a possible neuroprotective treatment in Parkinson?s disease. Currently, he is investigating the role of microglia and their proinflammatory processes in Parkinson?s disease.
Biography Updated on 27 December 2011